文献速递胃肠外科

微创Ivor Lewis食管切除术(MILE):100例连续病例的技术与结局

Minimally Invasive Ivor Lewis Esophagectomy (MILE): technique and outcomes of 100 consecutive cases.
PubMed 文献 · Surg Endosc · 2020-04-06

吻合口漏发生率为6%,30天和90天死亡率分别为2%和3%,平均住院时间10.3天。中位随访37个月时,3年和5年总生存率分别为63.9±5.0%和60.5±5.3%,3年和5年无病生存率分别为75.0±4.8%和70.4±5.5%。结论认为MILE围术期死亡率低,长期总生存和无病生存良好。

要点

  • MILE术后吻合口漏发生率为6%,30天和90天死亡率分别为2%和3%。
  • 平均住院时间10.3天,87例出院回家,12例转康复机构,1例院内死亡。
  • 3年和5年总生存率分别为63.9±5.0%和60.5±5.3%。

核心结论

  • MILE可安全实施,围术期死亡率低,长期总生存和无病生存良好。

主要发现

  • 主要诊断为食管癌96例,良性食管疾病4例。
  • 吻合口漏发生率为6%,30天和90天死亡率分别为2%和3%。
  • 平均住院时间10.3天,87例出院回家,12例转康复机构,1例院内死亡(移植物坏死)。
  • 平均随访37个月(范围2-74个月),3年和5年总生存率分别为63.9±5.0%(95%CI 53.3-72.7%)和60.5±5.3%(95%CI 49.4-69.9%)。
  • 3年和5年无病生存率分别为75.0±4.8%(95%CI 64.2-83.0%)和70.4±5.5%(95%CI 58.0-80.0%)。

临床怎么用

  • MILE可作为食管癌外科治疗的一种微创术式选择,需关注吻合口漏风险。

局限性

  • 回顾性单中心研究,样本量100例,随访时间有限,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Esophagectomy is the mainstay of therapy for esophageal cancer but is a complex operation that is associated with significantly high morbidity and mortality rates. The primary aim of this study is to report our perioperative outcomes, and long-term survival of Minimally Invasive Ivor Lewis Esophagectomy (MILE). METHODS: IRB approved retrospective study of 100 consecutive patients who underwent elective MILE from September 2013 to November 2017 at University of Florida, Jacksonville. RESULTS: Primary diagnosis was esophageal cancer (n = 96) and benign esophageal disease (n = 4). Anastomotic leak rate was observed in 6%; 30- and 90-day mortality rates were 2% and 3%, respectively. The mean length of hospital stay was 10.3 days; 87 patients were discharged to home, while 12 patients were discharged to rehabilitation facility, and there was one in-hospital mortality secondary to graft necrosis. At a mean follow-up was 37 months (2-74), the 3- and 5-year overall survivals are 63.9 ± 5.0% (95% CI 53.3-72.7%) and 60.5 ± 5.3% (95% CI 49.4-69.9%), respectively. The 3- and 5-year disease-free survival is 75.0 ± 4.8% (95% CI 64.2-83.0%) and 70.4 ± 5.5% (95% CI 58.0-80.0%). CONCLUSION: MILE can be performed with low perioperative mortality, and favorable long-term overall and disease-free survival.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Awad ZT, Abbas S, Puri R, et al. Minimally Invasive Ivor Lewis Esophagectomy (MILE): technique and outcomes of 100 consecutive cases. Surg Endosc. 2020. PMID: 32253561. doi:10.1007/s00464-020-07529-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。